Medicine for tuberculosis

As per available reports about 160 journals, 20 Conferences, 10 workshops are presently dedicated exclusively to tuberculosis and about 320 articles are being published on the current trends in Medicine for tuberculosis. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Medicine for tuberculosis are being carried out. As reported in tuberculosis article, Tuberculosis, or TB, is an infectious bacterial disease caused by Mycobacterium tuberculosis, which most commonly affects the lungs. It is transmitted from person to person via droplets from the throat and lungs of people with the active respiratory disease.In healthy people, infection with Mycobacterium tuberculosis often causes no symptoms, since the person's immune system acts to “wall off” the bacteria. The symptoms of active TB of the lung are coughing, sometimes with sputum or blood, chest pains, weakness, weight loss, fever and night sweats. Tuberculosis is treatable with a six-month course of antibiotics.

 The Journal of Pulmonary & Respiratory Medicine is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 7 journals in Medicine for tuberculosis. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Pulmonary & Respiratory Medicine provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Medicine for tuberculosis, thus bridging the gap between researchers and young scientists.